The Latest Breaking News from asthma

An estimated 22 million American adults are living with the chronic lung condition

Is your mattress triggering your allergies? Here are the five tell-tale signs that it is — and how you can fix it

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

The injection is the first new treatment for asthma and COPD attacks in 50 years

Labor has done a deal with the Greens on housing and the environment while the Coalition is expected to support migration and social media bills

Researchers say injection will be ‘game changing’ for people with the respiratory condition

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

Benralizumab is a monoclonal antibody that targets specific white blood cells

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

New guidelines say ‘greenhouse gas effect’ of treatment compares to environmental impact of long car journey